Product NDC: | 68180-185 |
Proprietary Name: | Mefenamic Acid |
Non Proprietary Name: | Mefenamic Acid |
Active Ingredient(s): | 250 mg/1 & nbsp; Mefenamic Acid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-185 |
Labeler Name: | LUPIN PHARMACEUTICALS INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091322 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110722 |
Package NDC: | 68180-185-13 |
Package Description: | 3 BLISTER PACK in 1 CARTON (68180-185-13) > 8 CAPSULE in 1 BLISTER PACK (68180-185-11) |
NDC Code | 68180-185-13 |
Proprietary Name | Mefenamic Acid |
Package Description | 3 BLISTER PACK in 1 CARTON (68180-185-13) > 8 CAPSULE in 1 BLISTER PACK (68180-185-11) |
Product NDC | 68180-185 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Mefenamic Acid |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110722 |
Marketing Category Name | ANDA |
Labeler Name | LUPIN PHARMACEUTICALS INC |
Substance Name | MEFENAMIC ACID |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |